John L. Higgins, Chief Executive Officer at LIGAND PHARMACEUTICALS INC (LGND), sold 20,000 shares at $78.32 ($1.6M) on 2022-11-17, disclosed to the SEC on 2022-11-21.
Open-market sale of $1.6M LGND by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.32 | 10,000 | $783K | 50.0% |
| 2 | $78.32 | 10,000 | $783K | 50.0% |
| Total | $78.32 avg | 20,000 | $1.6M | 100% |
| Filing → |
| OABI | BUY | 2025-03-21 | $9K | — | Filing → |
| OABI | BUY | 2025-03-20 | $591K | — | Filing → |
| TECH | SELL | 2024-05-16 | $335K | — | Filing → |